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ABSTRACT A large set of three-dimensional structures of 264 protein-protein complexes with known nonsynonymous single
nucleotide polymorphisms (nsSNPs) at the interface was built using homology-based methods. The nsSNPs were mapped on
the proteins’ structures and their effect on the binding energy was investigated with CHARMM force ﬁeld and continuum electrostatic calculations. Two sets of nsSNPs were studied: disease annotated Online Mendelian Inheritance in Man (OMIM) and
nonannotated (non-OMIM). It was demonstrated that OMIM nsSNPs tend to destabilize the electrostatic component of the
binding energy, in contrast with the effect of non-OMIM nsSNPs. In addition, it was shown that the change of the binding energy
upon amino acid substitutions is not related to the conservation of the net charge, hydrophobicity, or hydrogen bond network at
the interface. The results indicate that, generally, the effect of nsSNPs on protein-protein interactions cannot be predicted from
amino acids’ physico-chemical properties alone, since in many cases a substitution of a particular residue with another amino
acid having completely different polarity or hydrophobicity had little effect on the binding energy. Analysis of sequence conservation showed that nsSNP at highly conserved positions resulted in a large variance of the binding energy changes. In contrast,
amino acid substitutions corresponding to nsSNPs at nonconserved positions, on average, were not found to have a large effect
on binding afﬁnity. pKa calculations were performed and showed that amino acid substitutions could change the wild-type proton
uptake/release and thus resulting in different pH-dependence of the binding energy.

INTRODUCTION
Each individual possesses unique characteristics reflecting
their genotype, i.e., the uniqueness of the individual’s
DNA (1). For example, almost all nucleotide bases
(99.9%) are exactly the same in all people; however, the remaining 0.1% account for ~1.4 million individual-specific
differences (single nucleotide polymorphism, SNP) that
occur in humans. These differences may be within the coding
or noncoding regions of DNA and may or may not result in
amino acid changes, which, in turn, can either be harmless or
disease causing (2). From a computational biophysics point
of view, SNPs resulting in amino acid changes (nonsynonymous SNP, nsSNP) are of particular interest because such
changes should affect the stability of proteins and proteinprotein complexes.
From a biological perspective, the major factor contributing to the complexity of biological systems is the high
degree of connectivity on the molecular scale. In particular,
many proteins responsible for cellular functions rely on interactions with other proteins to perform these functions. If the
structures of the corresponding protein-protein complexes
are available, then we will have the opportunity to apply
theoretical biophysical methods to model the energetics of
protein-protein complexes (3–9) and apply the results in
structure-based drug design (10). Thus, understanding
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protein-protein interactions and their roles in cell function
will help reveal the molecular mechanisms of protein recognition and model the effect of perturbations on biological
network, in particular, the effects of nsSNPs on proteinprotein interactions (11–14).
The effects caused by nsSNPs can be broadly grouped into
four distinctive categories (15) (although the effects may be
mutually dependent) depending on what type of system or
process have been affected by nsSNPs: 1), protein folding,
stability, flexibility, and aggregation; 2), functional sites,
reaction kinetics, and dependence on the environmental
parameters, such as pH, salt concentration, and temperature;
3), protein expression and subcellular localization; and 4),
protein-small molecule, protein-protein, protein-DNA, and
protein-membrane interactions (see review and references
within (15)). Among these categories, the effect of nsSNPs
on protein stability (16–18) attracted most of the attention
of the scientific community. The mechanisms of the effect
of nsSNPs on protein stability could vary from geometrical
constraints (the mutation of a small side chain to a bulky
side chain in the protein interior), to physico-chemical effects
(replacement of hydrophobic residue with polar residue), to
the reversal of a charge within a salt bridge, or to the disruption of hydrogen bonds (19). For example, the nsSNPs resulting in changes of functionally important residues should
be almost always deleterious as they would block protein
function (20,21). However, since there are only a few functional residues within an entire protein sequence, the probability for such mutations is low (22). The possibility of an
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nsSNP affecting the subcellular location of a corresponding
protein was reported in a recent study that showed that in
~1% of cases the disease is caused by protein subcellular
delocalization (23). In addition to the above mentioned
effects, nsSNPs can change the kinetics of the corresponding
reactions as was experimentally shown in patients with
chronic lymphocytic leukemia (24) and inflammatory
diseases (25), or they can affect pharmacokinetics (26);
however modeling these effects is computationally difficult.
Although studies of the consequences of nsSNPs on proteins
have drawn much attention recently, the effect of nsSNPs on
protein-protein interactions has not been extensively investigated. This lack of attention may be a result of an insufficient
number of three-dimensional (3D) structures of proteinprotein complexes for which nsSNPs are known.
The recent progress made in experimental 3D structure
determination, led by the Structural Genomic Initiatives
(27), in addition to advances in computational modeling
(28,29), have made it possible to predict the effects of
nsSNPs by mapping them on corresponding structures or
on protein and protein-protein models. Indeed, structural
information was used in many studies to reveal the role of
SNPs on protein function and stability. A recent study on
human nsSNPs and disease-associated mutations in orthologous genes revealed that ~70% of disease-associated
mutations were in protein sites that most likely affect protein
function (30–33). Moreover, it was found that disease mutations are much more likely to occur at sites with low solvent
accessibility (32). Recently, a structure-based approach that
models residue-residue interaction networks was reported
(34). It applied graph theoretical measures to predict the residues that are important for structural stability. These results
imply that nsSNPs impact protein function and stability by
affecting their structures, which in turn might cause changes
in protein-protein or protein-ligand interactions.
It should be mentioned that most of the efforts in the field
so far have been aimed at predicting deleterious mutations,
since such predictions could be used for early diagnostics
and potential drug discovery (23,31,32,35–38). However,
the goals of our study are: 1), to investigate the possibility
that disease-causing and harmless nsSNPs affect proteinprotein interactions differently, and 2), to reveal the basic
principles of the effects of naturally occurring interfacial
nsSNPs on protein-protein interactions. The rationale behind
our approach is that any mutation at a protein-protein
complex interface should, in principle, somehow affect the
binding energy, and even harmless nsSNPs can also cause
dramatic changes in the phenotype resulting in natural differences among individuals. To deduce the effect of nsSNPs on
protein function, further investigation of the effect of nsSNPs
on protein-protein interaction network is needed, combined
with detailed analysis of the importance of the perturbed
interactions for normal cellular function.
In this study, we use homology modeling to construct 3D
models of a large number of protein-protein complexes (264)
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with known nsSNPs at their interfaces. The effect of amino
acid substitution resulted from nsSNPs on the protein-protein
binding energy was calculated using a standard force field
(CHARMM (39)), in contrast to previous studies that applied
descriptors or semiempirical functions. In addition, specific
attention was paid to possible ionization changes and charge
reorganization caused by the nsSNP mutations. The calculated effects are grouped into categories that describe several
distinctive mechanisms of nsSNPs affecting the energetics of
protein-protein interactions. The role of charge relaxation is
also investigated.
METHODS
Sequence alignment, template detection,
and model building
The first task was to extract query amino acid sequences associated with
nsSNPs and to search for available 3D structures or for 3D structures that
are homologous to the query sequences. The locus-id files for humans
were downloaded from build 126 of the dbSNP database, which contains
the SNPs associated with gene names and locations on genes. These files
also included accessions for protein sequences associated with the SNPs.
The protein sequences, which were found to be associated with SNPs,
were compared against the set of human protein structures (potential structural templates) (National Center for Biotechnology Information (NCBI)
Molecular Modeling DataBase (MMDB)) (40), using Blast algorithm (41).
The human structures that were found at an E-value of 10E–5 or better
were kept, resulting in 5.6 millions alignments. If a 3D structure of a query
protein was available, no modeling was required. Query proteins that
matched any of the entries in the Online Mendelian Inheritance in Man
(OMIM) database (42–44) were marked as ‘‘annotated’’ disease-causing.
The rest of the entries were considered undetermined with respect to possible
disease association and are referred to in the article as ‘‘nonannotated’’ or
‘‘non-OMIM’’.
At the second stage of processing, additional criteria were used requiring
that 80% of the query sequence be mutually aligned with the structural
template (nsSNPs that were not mapped in the alignment were discarded).
Only templates corresponding to protein-protein (or domain-domain)
complexes were used for modeling 3D structures of nsSNP-containing
sequences. During this procedure, we recorded whether or not the SNP
was on the interface for each chain/domain pair. It was done using querytemplate Blast alignments. Interface residues were defined as those being
8 Å from each other (distance was measured between Ca atoms) on different
chains/domains (45). These positions were flagged as interfacial residues.
The detected templates and corresponding sequence alignments were used
as input for the homology modeling. The 3D models were built with the
NEST program using the sequence alignment between queries and structural
templates (46). Identical alignments were discarded. The number of models
built for different degrees of modeling difficulty were as follows: 1), 1257
models were built by side chain replacement where query and template
sequences differed only by a few residues and the models were built by
mutating corresponding residues in the original chain and 2), 5274 models
were built with the NEST program. Because of the restrictive alignment
criteria applied above, in most of the cases, the alignment had very few
gaps/insertions, and thus the models were very close to the template structures. In total, 6531 protein models were constructed that corresponded to
the first allele (the first allele in case of OMIM is the dominant allele,
whereas in the case of non-OMIM it is simply the first allele in the list).
Then the monomeric proteins models were joined to the corresponding partners using the 3D structure of the template protein-protein complex. The
models of complexes were then evaluated according to the flagged interfacial positions, and only models with nsSNPs occurring at the interface of
Biophysical Journal 96(6) 2178–2188
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protein-protein complexes were retained for our study, resulting in 264
model structures.

DDDGðnsSNPÞ ¼ DDGðtarget: bindingÞ

Energy minimization
The structures of the 264 complexes were subjected to the TINKER package
(47) using the CHARMM27 force field parameters (39). The minimization
was done running the TINKER’s minimize.x module. The minimize.x
module performs energy minimization using the Limited Memory BFGS
Quasi-Newton Optimization algorithm (47). The implicit solvent was
modeled using the Still Generalized Born model (48), and the internal
dielectric constant was set to 1.0 to be consistent with the CHARMM27
force field parameters (49). The convergence criteria applied was root
mean-squared (RMS) gradient per atom ¼ 0.01. For energy minimization
calculations, we utilized a High Throughput Distributed Computing
Resource, CONDOR, originally developed at the University of Wisconsin-Madison (www.cs.wisc.edu/condor), which is now available at Clemson
University with more than 1080 single central processing units (CPUs) of
computational power.
The minimized 3D structures of the complexes with amino acids corresponding to the first reported allele in the dbSNP database were then used
to generate the corresponding nsSNP mutations. Utilizing the SCAP
program (50), the mutations, corresponding to either the second allele in
the dbSNP database or the disease-causing nsSNP in OMIM database,
were introduced using the above minimized model 3D structures, while
keeping the rest of the structure rigid, including the hydrogen atoms. In
case of homooligomeric-complexes, the nsSNP mutations were introduced
on both monomers. Then, the resulting 3D structures were minimized again
with TINKER using the same protocol that was described above.

Binding energy calculations
The binding energy was calculated with the so-called rigid body approach
keeping the structures of the monomers as they were in the complexes.
Such an approach is advantageous because the internal mechanical energies
of the unbound and bound monomers are the same and do not have to be
included in the calculations of the binding energy. Thus, the single point
calculations result in binding energy

DDGðbindingÞ ¼ DGðcomplexÞ  DGðAÞ  DGðBÞ; (1)
where DG(complex), DG(A), and DG(B) are the unfolding free energy for
the complex, monomer A, and monomer B, respectively. The total binding
energy and its two components (electrostatics and van del Waals) were
analyzed. The electrostatic component of the binding energy is the sum of
the Coulombic and reaction field energies as described in detail in (51,52):

DGel ðXÞ ¼ GðcoulÞ þ DGðrxnÞ;

(2)

where X stands for the complex, A and B monomers, respectively. G(Coul) is
the Coulombic interaction energy, and G(rxn) is the reaction field energy,
which is calculated with Delphi program (51,52).
The total binding energy is

DGtot ðXÞ ¼ DGðbondsÞ þ DGðvdWÞ þ DGðelÞ;

(3)

where DG(bonds) are the bonded energy terms, DG(vdW) is the van der
Waals energy, and DG(el) is the Coulombic interactions and solvation
energy calculated with the Generalized Born (GB) model. However, since
we adopted the rigid body approach, DG(bonds) for the complexes and
free monomers is the same and cancels in Eq. (3). All of the above energy
terms were calculated with the analyze.x module in TINKER. The nonpolar
component of the binding energy was not included in the calculations
because the single point mutation is not expected to change the binding interface significantly.
Changes in protein stability caused by the nsSNP mutation were calculated with respect to the energy of the target (the first reported allele or
Biophysical Journal 96(6) 2178–2188

wild-type allele in case of OMIM nsSNPs) protein. The corresponding quantity is DDDG(nsSNP), as described below:

 DDGðnsSNP: bindingÞ:

(4)

The changes of the total binding energy (DDDGtot(nsSNP)), as well as the
change of its vdW (DDDGvdw(nsSNP)) and electrostatic (DDDGel(nsSNP))
components are analyzed in this work. If the change is negative, this indicates that the nsSNP mutation weakens the affinity and destabilizes the
complex, whereas if the change is positive then the mutant binding is tighter.

Multiple sequence alignment
Protein sequences from different species were downloaded from the NCBI
Entrez database, using GENE search option and submitting each of the
gene’s ID as a query. Only cases for which a protein was found in more
than four species were considered, and the multiple sequence alignments
(MSAs) were built resulting in 227 out of the total 264 sequences. We
used the European Bioinformatic Institute’s ClustalW2 web service (http://
www.ebi.ac.uk/Tools/clustalw2/index.html) to perform MSAs.

pKa calculations of the ionizable states
and proton uptake/release
The pKa values of the ionizable groups were calculated using the Multi
Conformation Continuum Electrostatics (MCCE) method as previously
described (53–55). Recently, we demonstrated that MCCE can be utilized
to calculate pKas using 3D structures that were built by homology (56).
Calculations were performed for all 264 protein complexes corresponding
to the first allele, and another set of pKa calculations were done for the
protein complexes with corresponding nsSNP mutation. The calculations
were also performed on the corresponding unbound monomers, whose structures were taken from the corresponding protein-protein complex. These
results were used to predict the changes of the titratable groups’ ionization
states caused by complex formation. For each complex, we calculated the
difference of the net charge (Dq(X)) of the complex and of the unbound
monomers, called proton uptake/release:

DqðXÞ ¼ qðX : complexÞ  qðX : AÞ  qðX : BÞ;

(5)

where X is the first allele or nsSNP variant, and q is the net charge of the
complex and of monomer A and B, respectively, calculated with MCCE at
a pH of 7.0. We chose a pH of 7.0 because there was no information of
what the physiological pH is for each of the proteins studied in this manuscript. In addition, we analyzed the proton uptake/release difference between
complexes with the first allele and the nsSNP variant:

DDq ¼ absðDqðdominant alleleÞ  DqðnsSNPÞÞ:

(6)

p-Value calculations
The p-values were calculated performing a t-test (57–59). The distributions of
the corresponding changes of the binding energy and its components in case
of OMIM and non-OMIM sets were checked against the null hypothesis. A
large p-value indicates that the corresponding distribution is similar to the
normal distribution (null hypothesis), whereas a small p-value points out
a deviation from random distribution. A typical cut-off for p-value is 0.01,
i.e., distribution with the p-value smaller than 0.01 is considered significantly
different from random. The distribution of the variance of DDDGtot(nsSNP)
and DDDGel(nsSNP) was checked against the null hypothesis that assumes
equal variances. The SI% scale was divided into five bins, corresponding to
cases with SI% smaller than 20%, 20% < SI% < 40%, 40% < SI% <
60%, 60% < SI% < 80, and 80% < SI% < 100%. The variance of the corresponding energies was calculated within each of the bins and the resulting
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FIGURE 1 Distribution of DDDGtot(nsSNP) and
DDDGel(nsSNP) in kcal/mol for OMIM and non-OMIM
cases. Solid bars, OMIM; open bars, non-OMIM.

p-value evaluated. In case of DDq, six bins were considered: 0.00 < DDq
< 0.05, 0.05 < DDq < 0.10, 0.10 < DDq < 0.15, 0.15 < DDq < 0.20,
0.20 < DDq < 0.25, and DDq > 0.25. Then, the variance of the corresponding
energies within these bins and the p-value were calculated.

RESULTS AND DISCUSSION
Distribution of binding energy
The changes in the total binding energy and its electrostatic
and vdW components due to the nsSNPs were calculated
for all complexes in the data set (Fig. 1, Table 1). The distributions of DDDGtot(snSNP) for OMIM and non-OMIM
cases are shown in Fig. 1 a. It can be seen that the distributions have similar shapes, showing a slight tendency toward
negative values. The mean values of electrostatic
(DDDGel(snSNP)) and vdW (DDDGvdw(snSNP)) components of the binding energy changes are statistically different
for OMIM and non-OMIM cases (p-values are <0.006 and
0.01, respectively), although this is not the case for the total
binding energy. Fig. 1 b shows the distribution of
DDDGel(snSNP) for both OMIM and non-OMIM cases.
One can see the long negative tail of the distribution of
OMIM cases for which nsSNP substitutions destabilize
binding. Moreover, the mean of OMIM distribution of electrostatic energy is significantly different from zero and shifted
toward negative values although this is not the case for nonOMIM distribution of electrostatic component (Table 1).
This indicates that, overall, there is a tendency for OMIM
nsSNP substitutions to weaken the electrostatic component
of the binding energy, although there are many examples
where disease nsSNPs make binding tighter as well. The
effect is less pronounced for the total binding energy.

From an electrostatic point of view, replacing the wildtype amino acid (dominant allele) at a protein-protein interface with another amino acid (amino acid which corresponds
to nsSNP) is expected to be a destabilizing event. Indeed, in
our previous study of 654 protein-protein and domaindomain complexes, we demonstrated that the electrostatic
component of the binding energy tends to be optimized
(60) with respect to random shuffling of the amino acid
sequences of the corresponding binding partners. Thus, since
wild-type (dominant allele) interactions across the interface
are optimized, any change should make the binding affinity
weaker. Indeed, the destabilization effect upon disease
substitutions is the most pronounced in case of the electrostatic component of binding energy (DDDGel distributions
is shifted toward negative values with a p-value of
<0.003). However, the tendency of OMIM mutations to
destabilize the electrostatic component of the binding energy
is not very strong, which perhaps stems from the fact that
nsSNP substitutions are not random, rather they are constrained mutations accepted by the cell. At the same time,
for non-OMIM substitutions the electrostatic component
should be optimized for both alleles and consequently the
mean of DDDGel(nsSNP) is not statistically significantly
different from zero (p-value is 0.06).
Despite the differences, in the majority of the cases, both
OMIM and non-OMIM substitutions were calculated to have
little effect on binding. Since we investigate nsSNP substitutions at the interface of protein complexes, this observation
deserves further investigation. The next sections investigate
possible patterns and correlations between different types of
amino acid substitutions and their calculated effects on
binding energy.

TABLE 1 Parameters of distributions of total binding energy difference and their components in kcal/mol together with the
corresponding p-values (the null hypothesis that mean value R 0 is rejected if p < 0.01)
DDDGtot

DDDGvdw

DDDGel

Group

No.

Mean

Std

p-Value

Mean

Std

p-Value

Mean

Std

p-Value

OMIM
Non-OMIM
Polar (P)
Charge (C)
Small (S)
Hydrophobic (H)

45
219
62
76
94
32

1.65
0.70
0.27
2.01
0.74
0.32

3.80
4.36
3.77
6.38
2.39
2.50

0.003
0.009
0.28
0.004
0.002
0.77

1.03
0.14
0.38
0.33
0.03
0.36

3.32
3.03
3.94
2.25
2.49
4.46

0.02
0.75
0.77
0.1
0.45
0.32

2.35
0.45
0.83
1.37
0.78
0.74

5.51
4.39
4.74
6.59
2.58
3.23

0.003
0.06
0.09
0.04
0.002
0.09
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FIGURE 2 Illustration of nsSNPs at interface of proteinprotein complexes: (a) TTR (transthyretin, gene ID:
4507725), red, A chain; blue, E chain; green, Ser in A85;
yellow, F in A85; magenta, N in E63. (b) DYNLRB1
(Roadblock-1, gene ID: 7661822), red, A chain of target;
light red, A chain of SNP variants; blue, B chain of target;
sky blue, B chain of SNP variant; green, K in A75; yellow,
E in A75; magenta, D in B61 of target; pink, D in B61 of
SNP variant. (c) HBB (b-globin, gene ID: 4504349), red, B
chain; blue, C chain; green, V in B34; yellow, L in B34. (d)
GSTM2 (glutathione S-transferase M2, gene ID: 4504175),
red, A chain; blue, B chain; green, M in A130; yellow, K in
A130; magenta, M in B50.

Effect of nsSNPs on binding energy with respect
to amino acid characteristics
In this section, four different classes of amino acids were
considered based on the amino acids’ physico-chemical
properties: polar (S, T, H, N, Q, Y), charged (E, D, K, R),
hydrophobic (W, I, L, M, F), and small (P, A, G, C, V).
We adopt this simplified classification to ensure that each
class has enough representatives in our data set. Of course,
many other classifications exist, including more detailed
definitions of the subgroups. Below we investigate the
effects of nsSNP mutations on the DDDGtot(snSNP),
DDDGvdw(nsSNP), and DDDGel(nsSNP) separately for
each class (more detailed analysis including analysis of the
effects of substitutions between classes is given in the Supporting Material).
Binding energy changes caused by a substitution of a polar
amino acid

There are 62 cases in our data set for which a polar residue
corresponding to the first allele and located at the interface
of the protein-protein complex is substituted by another
variant (Table 1). Overall, there is no statistically significant
bias for energy to be shifted upon substitution toward lower
or higher values.
From an electrostatic point of view, a polar/another
amino acid substitution tends to be an unfavorable event in
the majority of cases (p ¼ 0.09). In another words, removal
of a polar group at the interface, despite structural refinement, makes electrostatic binding energy less favorable.
Further analysis of such cases showed that a removal of
a polar residue disturbs the hydrogen bond network at the
interface. Substitution of a polar residue with either small,
charged, or hydrophobic groups tends to make the electrostatic component of binding weaker. A small residue will
create energetically unfavorable cavities, a charged residue
Biophysical Journal 96(6) 2178–2188

will pay a large desolvation penalty, and a hydrophobic
residue will not be able to provide the required hydrogen
bonds. However, exceptions are cases when a polar group
is replaced by another polar residue whose side chain can
satisfy the required geometry. In the last case, the electrostatics may not change or even become more favorable.
A particular example of a polar/hydrophobic substitution is shown in Fig. 2 a. It demonstrates that removal of
a polar residue and substitution with a hydrophobic residue
results in the placement of the hydrophobic side chain in
a polar environment, an event that weakens the binding
affinity. A typical case is Transthyretin (TTR), which is
a plasma protein that binds retinol and thyroxine. Many
distinct forms of amyloidosis are related to different nsSNPs
in TTR. For example, the nsSNP (refSNP ID: rs11541784)
results in a change of the polar (Ser) residue into a hydrophobic residue (Phe). The nsSNP Phe residue is located in
a polar environment and reduces the binding affinity by
0.717 kcal/mol.
Binding energy changes caused by a substitution
of a charged amino acid

There are 76 cases in our data set in which a charged residue
located at the interface of the target protein-protein complex
is substituted in the nsSNP variant (Table 1). The values of
the means of DDDGtot(nsSNP) and its electrostatic component DDDGel(nsSNP) are negative and this bias is statistically significant (p-values 0.004 and 0.04, respectively),
which means that the target protein-protein complexes are
more stable compared to the nsSNP variants.
Substituting a charged with another residue is, overall, an
unfavorable event with respect to protein-protein association
(Table 1). Removal of a charged residue that forms a salt
bridge across the interface in the target complex leaves the
charged partner without favorable pair-wise interactions.

Modeling Effects of Human SNPs

The remaining charged residue pays a huge desolvation
penalty upon complex formation, which in the nsSNP variant
may not be compensated by favorable pair-wise interactions.
This provides an intuitive explanation why distributions of
both the DDDGtot(nsSNP) and DDDGel(nsSNP) are shifted
toward negative values .
The mutation of a charged amino acid to another charged
amino acid (charged/charged) is an interesting case. The
mutation could preserve the charge (Asp 4 Glu; Lys 4
Arg) or invert the charge (Asp,Glu 4 Lys, Arg). Presumably,
a mutation that preserves the charge should have a lesser effect
on the binding energy as compared with charge-reversal
mutations. However, our analysis showed that this is not
always the case. Overall, all mutations of the target charged
residue to another charged residue were found to be unfavorable events (Table 1). Even in the case of Glu to Asp substitutions, like aldolase B (Glu to Asp in position 64), which is
a mutation (refSNP ID: 2854709) that preserves the net charge
of the complex, the change of the binding energy is huge:
DDDGtot(nsSNP) ¼ 9.06 kcal/mol, DDDGvdw(nsSNP) ¼
1.58 kcal/mol, and DDDGel(nsSNP) ¼ 11.30 kcal/mol.
This change is due to the fact that the side chain of Asp is
shorter than the Glu side chain, and the nsSNP introduced
Asp cannot form a strong salt bridge with the original partner
Lys in position 270 of the other chain in this homo-dimer
complex. Another example (Fig. 2 b) is the case of charge
reversal in Roadblock-1 (DYNLRB1), which is a homodimeric protein that may be involved in tumor progression,
as the upregulation of this gene is associated with hepatocellular carcinomas. The corresponding nsSNP (refSNP ID:
rs11537531) of this protein results in the change of a Lys
amino acid to a Glu amino acid at the complex’s interface.
In the target protein complex, the distance between Lys75
from chain A and its partner Asp61 from chain D is only
1.62 Å, resulting in a very strong hydrogen bond and pairwise electrostatic interactions. However, in the nsSNP
variant, the positively charged Lys is replaced by Glu, a negatively charged residue. Due to minimization, the distance
between the nsSNP residue and the original Asp61 from chain
D increases to 9.99Å because of the repulsive charge-charge
interaction between the two negatively charged groups (Fig. 2 b).
This reduces the effect, but the binding energy is still much
less favorable as compared with the dominant allele. The corresponding energy changes are DDDGtot(nsSNP) ¼ 11.13
kcal/mol, DDDGvdw(nsSNP) ¼ 4.42 kcal/mol, and
DDDGel(nsSNP) ¼ 3.08 kcal/mol. This is an example of
a structural relaxation that reduces the effects of charge
reversal.
Binding energy changes caused by a substitution of a small
amino acid

There are 94 cases in our data set for which a small residue
located at the interface of the target protein-protein complex
is substituted into the nsSNP variant (Table 1). Overall, the
total binding energy and electrostatic components are signif-
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icantly (both p-values are 0.002) shifted toward negative
values, which indicates that nsSNP destabilizes the complex.
Substitution of a small with another amino acid almost
always will result in sterical clashes. The volume of a small
amino acid is much smaller than the volume of the other residues. Thus, there will be no room for a bulky amino acid side
chain at the interface. Such a replacement will cause distortion of the interface and will weaken the binding (Table 1). A
typical example is the histidine triad nucleotide binding
protein 1 (HINT1), Gene ID: 4885413. The nsSNP codes
for Gly to Arg substitution in position 92 of B chain. The
substitution introduces a new charged residue, which pays
a large desolvation penalty, and the resulting change in the
electrostatic component of the binding energy DDDGel(nsSNP)
is 9.23 kcal/mol).
However, there are also opposite examples, indicating that
protein complexes can tolerate small amino acid substitutions
at the interfaces. A typical example is Human b-globin (HBB),
which regulates developmental expression. The corresponding nsSNP (refSNP ID: rs1141387) in this protein replaces
a Val residue with a Leu amino acid. Despite the difference
in these two amino acids’ volumes, the structure of
the complex does not change by much, resulting in smaller
energy differences: DDDGtot(nsSNP) ¼ 0.98 kcal/mol,
DDDGvdw(nsSNP) ¼ 0.01 kcal/mol, and DDDGel(nsSNP)
¼ 1.21 kcal/mol (Fig. 2 c). The main reason for this small
difference is that both side chains are partially exposed to the
solution, and there is room for a larger Leu side chain.
Binding energy changes caused by a substitution of a hydrophobic amino acid

There are 32 cases in our data set in which a hydrophobic
residue located at the interface of the target protein-protein
complex is substituted by the nsSNP variant (Table 1). The
mean values of all energy distributions are not significantly
different from zero. In general, substituting a hydrophobic
residue at the interface with another residue does not have
a large effect on protein-protein binding. Perhaps this is
due to the fact that hydrophobic groups do not form specific
interactions. Thus, the effect of a replacement of a particular
hydrophobic side chain with another residue depends on the
geometry of the interface and the ability of the substituted
side chain to form new interactions. For example, a polar
or charged residue, substituting a hydrophobic one, could
increase the binding affinity only if the corresponding
residue manages to create new favorable interactions across
the interface. If this does not occur, then the mutation should
weaken the binding. Such a case is shown in Fig. 2 d. Glutathione S-transferase M2 (GSTM2) is an important enzyme
that contributes to the metabolism of phase II biotransformation of xenobiotics. The corresponding nsSNP (refSNP ID:
rs1056799) changes the target amino acid Met to Lys in position A130. However, the new charged residue cannot form
favorable interactions with any other residue across the interface since it is in a hydrophobic environment. As a result, the
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solvation loss cannot be compensated for, and the mutation
weakens the binding.
Correlation of the calculated effect on the binding
afﬁnity and residue conservation
MSAs were used for phylogenetic analysis and for determining the evolutionary relationships between different
species. Only positions corresponding to interfacial sites
were considered. A position in the MSA that is totally or
highly conserved indicates strong evolutionary constraints,
and the substitution of such a highly conserved amino acid
is expected to have significant effects on protein structure,
function, and interactions. In contrast, an amino acid that is
not conserved among different species is, perhaps, not
crucial for the structure, function, and interactions of that
particular protein complex.
We began our analysis with a case corresponding to
a highly conserved site. Position B34 in human b-globin
(HBB) is totally conserved among the species (Fig. 3 a).
The nsSNP causes a mutation that changes Val residue to
Leu. As result, the total binding energy, van der Waals and
electrostatic components are more favorable in the target
complex compared with the nsSNP variant. The corresponding changes of the binding energy are DDDGtot(nsSNP) ¼
0.98 kcal/mol, DDDGvdw(nsSNP) ¼ 0.01 kcal/mol, and
DDDGel(nsSNP) ¼ 1.21 kcal/mol.
Another example is glutathione S-transferase M2
(GSTM2) (Fig. 3 b). Position A130 is not conserved; in humans it is a Met residue, however, in other species the same
position is a Lys amino acid. The nsSNP induces a Met /
Lys change in the human protein, a mutation that is already
seen in other species. Perhaps this explains why such a drastic
change (a hydrophobic to a charged group) has little effect on
the binding affinity. The corresponding changes of the
binding energy are DDDGtot(nsSNP) ¼ 0.53 kcal/mol,
DDDGvdw(nsSNP) ¼ 0.28 kcal/mol, and DDDGel(nsSNP)
¼ 0.26 kcal/mol.
The magnitude of the binding energy change as a function
of the degree of conservation is shown in Fig. 4. It can be
seen that as the degree of conservation increases (calculated
in terms of percent identity, SI%) the maximal amplitude
of both the DDDGtot(nsSNP) and the DDDGel(nsSNP)

FIGURE 3 MSA. Blank frame is nsSNP position. (a) HBB (b-globin,
gene ID: 4504349); (b) GSTM2 (glutathione S-transferase M2, gene ID:
4504175).

increases as well (illustrated by the broken lines in Fig. 4).
The effect culminates at high SI% (SI% > 80%) where the
variance of the magnitude of both the DDDGtot(nsSNP)
and the DDDGel(nsSNP) is significantly different, i.e., the
null hypothesis about the equality of variances between the
bins was rejected with p < 0.00001 (see Methods section).
Note that this result corresponds to significant variance of
the binding constant resulting to either increase/decrease or
no change of the affinity. The points located close to the horizontal axis and corresponding to highly conserved positions
(Fig. 4) indicate that in some cases, a mutation of a highly
conserved amino acid may not affect the binding affinity.
In these cases, the effect depends on the geometry of the
interface and where the site is situated. These highly
conserved sites are predominantly located at the periphery
of the binding interface and apparently are not important
for the binding affinity. Fig. 4 provides indirect support
demonstrating that the calculated effects are reasonable,
since no large binding energy change was calculated to be
associated with nonconserved positions in the MSA.
Effect of nsSNPs on proton uptake/release
Fig. 5 shows the change of the corresponding binding energy
as a function of the absolute difference of the proton uptake/
release for target complexes and an nsSNP variant calculated
at pH ¼ 7.0. No correlation between either the magnitude or
variance of the binding energy change and DDq was found.
At the same time, it can be seen that most DDq are close

FIGURE 4 Change of the binding energy in kcal/mol as
a function of the amino acid conservation (SI%). The
broken lines are guides for the eye and follow the maximal
amplitude of binding energy change. (a) DDDGtot(nsSNP);
(b) DDDGel(nsSNP).
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FIGURE 5 Change of the binding energy in kcal/mol as
a function of calculated proton uptake/release (absolute
value of DDq). (a) DDDGtot(nsSNP); (b) DDDGel(nsSNP).

to zero, indicating that at least around a pH of 7.0 the
pH-dependences of the binding energy are the same for the
target complex and the nsSNP variant. However, this is not
necessarily the case for the entire pH-dependence. At the
same time, there is significant percentage of cases in which
the DDq is different from zero. This indicates that nsSNP
mutations not only change the binding energy but also result
in a different pH-dependence of the binding. This could have
a significant physiological importance; however, there is
practically no experimental data available for comparison.
In general any substitution can lead to ionization changes.
The above results indicate that amino acid substitutions corresponding to nsSNPs not only change the binding energy
but could also result in changes in the ionization states of
the titratable groups. Such an effect could occur not only
when a titratable group is involved in the target/ nsSNP
mutation but could also occur in each of the other cases as
well. This is because any substitution changes the geometry
of the interface and thus affects the electrostatic potential of
all ionizable residues. However, in this study we did not
perform charge relaxation, i.e., no attempt was made to
adjust the residues’ ionization states according to the pKa
calculations because the calculated proton uptake/release is
a fractional number. Modeling fractional ionization in single
point calculations is impossible and any attempt would be an
error (see for details (61)). However, a more sophisticated
approach involving ensemble presentation could take into
account these ionization changes and will result in a reduction of the magnitude of the energy change caused by the
nsSNP mutation. Thus, all of the data points (Fig. 5) corresponding to DDq that are significantly different from zero
may get closer to DDDG (nsSNP) ¼ 0, i.e., closer to the horizontal axis. Perhaps this is an effect that occurs in vivo and
results in toleration of nsSNP mutations. Site-directed mutagenesis experiments and complementary numerical calculations have proven the charge-compensatory effect (62–64).
Perhaps, the charge-compensatory effect is the reason that
maximal DDq (Fig. 5) is only ~0.6 units, despite that some
nsSNPs cause charge reversal.
CONCLUSION
This analysis is focused on nsSNPs located at protein-protein
interfaces. Protein-protein interactions are essential for cell
function, and nsSNPs affecting these interactions are ex-

pected to have significant impacts on the protein interaction
network. Indeed, our analysis showed that OMIM and some
non-OMIM nsSNP might have a significant effect on
binding energy especially on the electrostatic component.
Although the effect is statistically significant, the majority
of amino acid substitutions corresponding to nsSNP does
not affect the binding affinity by much. This observation
should be taken with caution. A small change of the binding
affinity by a kcal/mol or even less could still disrupt the functionality of the interaction network or change the kinetics of
the corresponding reaction (24,25). However, investigating
this effect requires modeling protein-protein networks,
a task that is far beyond the goals of this study.
Two data sets were considered in this study: nsSNPs that
are known to be disease-causing (OMIM data set) and
nsSNPs that were not annotated to be disease-causing
(non-OMIM). The distributions of the change in the binding
energy and its components in both the OMIM and
non-OMIM cases were found to be different although the
difference is small. However, looking at the electrostatic
component of the free energy we found that it is significantly
shifted toward negative values for OMIM nsSNP, while this
is not the case for non-OMIM nsSNPs. This indicates that
disease-causing nsSNPs tend to destabilize the electrostatic
component of protein-binding energy, in contrast with nonOMIM nsSNPs.
Although a large number of nsSNPs did not affect protein
interactions by much (perhaps showing the plasticity of
protein interfaces and their ability to tolerate amino acid
changes), an even larger fraction of the nsSNPs did affect
the affinity. In fact, about half of nsSNPs destabilize/stabilize
the complexes by more than 1 kcal/mol. In addition, we find
that 31.8% of nsSNPs affect protein-protein binding by more
than 2 kcal/mol and 23.9% by more than 3 kcal/mol.
As was mentioned previously, in the case of non-OMIM
complexes there is no information about which nsSNP is
the dominant allele. However, our numerical protocol builds
a 3D model of the first allele in the list, minimizes the structure, and then introduces a side chain mutation at the nsSNP
position and minimizes the mutant structure. Could this
protocol bias the calculations? Since DDDG(nsSNP) is
a difference between two binding energies, the change of
the order will simply change the sign of the DDDG(nsSNP).
If the numerical protocol is not biased, then we should see that
the effect of, for example, a P/C mutation is opposite to the
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effect of a C/P variation. Comparing the means reported in
the Supporting Material, Table S1, we can see that this is the
case, except for C/H and H/C (in both cases the means of
the distributions of DDDGtot(nsSNP) were found to be negative). However, this is the smallest subset in our study
composed of only five cases, many more examples are
needed to draw a conclusion.
Another important issue to address is how sensitive the
results are in respect to the computational protocol and force
field used. Recently we have demonstrated that the calculations of absolute value of the binding energy are very sensitive to both computational protocol and force fields (65). The
same study (65), however, found that the distribution of the
binding energy and the general trends are almost insensitive
to the force field and protocol used. Since this study is not
aimed at computing the absolute binding energy, but rather
the change of the binding energy upon single amino acid
substitution, the effects of force field and computational
algorithm are expected to largely cancel out.
It is expected that a mutation that changes the physicochemical property of a position at the interface of the corresponding protein-protein complex should affect binding
affinity. However, our results indicate that this is not necessarily the case. The outcome of the mutation depends on
a variety of factors, whose interplay determines the effects
of the substitution. In addition, some positions are located
in structural regions that allow for structural relaxations.
From an energetics perspective, an amino acid substitution
may not always affect the binding affinity. An example
includes a charged residue for which the favorable pairwise interactions are almost entirely cancelled by an unfavorable desolvation penalty. Another example is weak hydrogen
bonds formed at the interface. A third example is a partially
exposed hydrophobic residue at the periphery of the interface. Substitution of such residues with another may not
affect the binding affinity; in fact, the nsSNP mutation could
strengthen the binding.
A highly conserved position within the protein sequence is
often related to an important biological function. Multiple
sequence alignment analysis showed that most of the positions corresponding to interfacial nsSNPs in our data set
are highly conserved. It was shown that the variance of the
total binding energy and its components of the highly
conserved positions is larger as compared with the variance
of positions with lower conservation. However, a significant
fraction of nsSNP occurring at conserved positions was
calculated not to change the binding energy by much. This
observation indicates that conservation of amino acids in
certain interface positions does not occur to preserve binding
affinity. Rather, such conservation may reflect the preservation of the binding mode or specificity. An interesting case is
an nsSNP mutation that introduces an amino acid found in
another species. Since such a mutation was evolutionarily
accepted in the other species, the overall effect on proteinprotein affinity is expected to be small. In further work, we
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will explore this observation and will determine the effects
of introducing mutations to any other 20 amino acids.
We showed here that that the change of the binding energy
from the target complex to the nsSNP variant is not related to
the conservation of the net charge, hydrophobicity, or
hydrogen bond network. This result implies that one cannot
simply use the physical-chemical properties of amino acids
to evaluate the effects an nsSNP has on protein-protein interactions. Rather, as we have done here, detailed structure-based
energy calculations must be performed to predict these effects.
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